TwinPharma contributes to improve the health care in the Netherlands, Belgium and Luxembourg.
We do this by introducing added value medicines that up to now were not available in these countries.

Hepatect CP

Hepatect CP contains mainly IgG with a specifically high content of antibodies against hepatitis B virus surface antigen.

hepatec

Megalotect 100 E/ml

Megalotect 100 E/ml is an immunoglobulin preparation from plasma of donors with a high antibody titer against the cytomegalovirus.

megalotect

Zutectra

Prevention of hepatitis B virus re-infection in HBsAg and HBV-DNA negative adult patients at least one week after liver transplantation for hepatitis B induced liver failure.

zutectra

Interim & advice

Open positions, replacement or extra activities? TwinPharma can offer a solution.

Hartelijk welkom bij TwinPharma!

We hebben deze site gemaakt om makkelijker met u in contact te kunnen komen. Voor een eerste kennismaking, om een idee te krijgen van onze geneesmiddelen of om onze filosofie en de manier van werken waar wij achter staan met u te delen. Wees welkom en kijk eens rond. Wij stellen uw reactie zeer op prijs en hopen u zo snel mogelijk persoonlijk te spreken.

Hartelijke groet,

Bauke Buwalda en Gert van Alewijk

E-mail: info@twinpharma.com

Are you looking for a distributor of medicines in Europe?

TwinPharma and Anthrop Pharmaceuticals joined forces and reaching out to more than 50 million Europeans in 7 countries.

50me-logo

Local Dutch-Belgian full service consultancy market access chain

Achieving reimbursement and price are the 2 most important drivers for a successful launch of an innovative medicine in the Netherlands and Belgium.
TwinPharma is working in a network with specialised partners in market access, pricing, pharmaco-economics, regulatory and KOL-management in the Netherlands and Belgium.